In this context the company recently finalised two acquisitions and a strategic partnership. Symrise purchased the Brazilian activities of fragrance manufacturer Belmay and will transfer these to its own site.
Symrise is also strengthening its dynamically growing natural ingredients business with its acquisition of the US manufacturer Trilogy Fragrances. In addition, the company agreed to a strategic partnership with the Swedish biotech firm Indevex regarding the similarly expanding segment of Consumer Health.
Dr Heinz-Jürgen Bertram, CEO of Symrise, said: “We continue to follow our strategy of extending Symrise’s position in the rapidly expanding emerging markets and sharpening our unique profile with our expansion into innovative market segments.
“We are especially pleased that, at the start of the new fiscal year, we can announce three measures that put these goals into practice. For consumers in developed nations, having a healthy lifestyle is playing an increasingly important role.
“Through our strategic partnership with Indevex Biotech, we are selectively expanding our expertise in functional foods and creating an optimal foundation for further product innovations. The purchase of Trilogy Fragrances expands our portfolio of natural perfume oils, particularly in North America.”
Dr Bertram added: “In the dynamically growing countries of Latin and South America, the rising standard of living is driving demand for consumer goods. We allow for this situation with the purchase of Belmay’s perfume activities in Brazil – one of the most populous countries on earth.”
Source: Symrise
© FoodBev Media Ltd 2024